INT280053

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2009
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.71
Pain Relevance 0.10

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Golgi apparatus (Dpp4) endoplasmic reticulum (Dpp4) DNA binding (Zglp1)
peptidase activity (Dpp4) extracellular region (Dpp4) cell adhesion (Dpp4)
Dpp4 (Mus musculus)
Zglp1 (Mus musculus)
Pain Link Frequency Relevance Heat
agonist 33 87.60 High High
cytokine 2 5.00 Very Low Very Low Very Low
ischemia 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
withdrawal 1 5.00 Very Low Very Low Very Low
Inflammatory marker 1 5.00 Very Low Very Low Very Low
Neuropeptide 1 5.00 Very Low Very Low Very Low
abdominal pain 1 5.00 Very Low Very Low Very Low
Paracetamol 1 5.00 Very Low Very Low Very Low
rheumatoid arthritis 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Targeted Disruption 3 98.16 Very High Very High Very High
Weight Loss 14 96.08 Very High Very High Very High
Hypoglycemia 30 95.44 Very High Very High Very High
Hyperinsulinism 2 95.44 Very High Very High Very High
Diabetes Mellitus 103 92.20 High High
Vomiting 10 36.48 Quite Low
Obesity 8 13.76 Low Low
Body Weight 12 5.00 Very Low Very Low Very Low
Hyperglycemia 8 5.00 Very Low Very Low Very Low
Pancreatitis 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Prevention of GLP-1 degradation by pharmacological DPP-4 inhibition in pigs,90 and genetic inactivation in DPP-4 knockout mice,91 increase endogenous total GLP-1 levels, leading to increased insulin secretion and reduced fasting and postprandial glucose concentrations.
Negative_regulation (inhibition) of DPP-4 Negative_regulation (Prevention) of Protein_catabolism (degradation) of GLP-1 associated with targeted disruption and hyperinsulinism
1) Confidence 0.02 Published 2009 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2731024 Disease Relevance 0.71 Pain Relevance 0.10

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox